Literature DB >> 17577214

Regulation of arginase-1 expression in macrophages by a protein kinase A type I and histone deacetylase dependent pathway.

Ivonne Haffner1, Daniel Teupser, Lesca M Holdt, Jana Ernst, Ralph Burkhardt, Joachim Thiery.   

Abstract

The aim of the current study was to investigate the cAMP-dependent regulation of arginase-1 (ARG1) expression in RAW-macrophages. Basal ARG1 mRNA expression was low and increased upon incubation with the cAMP analogue Br-cAMP. We used selective agonists of protein kinase A type I (PKAI), type II (PKAII) and exchange protein directly activated by cAMP (EPAC) to determine the pathway responsible for ARG1 expression. Activation of PKAI led to a significant up-regulation of ARG1 mRNA expression and arginase enzyme activity. In contrast, neither activation of PKAII nor activation of EPAC affected ARG1 expression. In addition, it has been shown that histone deacetylase (HDAC) activity plays a critical role in cAMP-dependent transcriptional regulation. Incubation with Br-cAMP and the HDAC inhibitor trichostatin A (TSA) led to a concentration-dependent suppression of ARG1 expression. These data indicate that cAMP-dependent activation of ARG1 expression is mediated by PKAI and requires histone deacetylation. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17577214     DOI: 10.1002/jcb.21422

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Arginase in parasitic infections: macrophage activation, immunosuppression, and intracellular signals.

Authors:  Cinthia C Stempin; Laura R Dulgerian; Vanina V Garrido; Fabio M Cerban
Journal:  J Biomed Biotechnol       Date:  2009-12-09

2.  Pharmacologic agents elevating cAMP prevent arginase II expression and proliferation of pulmonary artery smooth muscle cells.

Authors:  Bernadette Chen; Andrea E Calvert; Xiaomei Meng; Leif D Nelin
Journal:  Am J Respir Cell Mol Biol       Date:  2012-03-23       Impact factor: 6.914

Review 3.  Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors.

Authors:  Khaled S Abdelkawy; Kelsey Lack; Fawzy Elbarbry
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

Review 4.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 5.  Arginase: an emerging key player in the mammalian immune system.

Authors:  Markus Munder
Journal:  Br J Pharmacol       Date:  2009-09-17       Impact factor: 8.739

6.  Transcriptional regulation of endothelial arginase 2 by histone deacetylase 2.

Authors:  Lewis Romer; Dan Berkowitz; Deepesh Pandey; Gautam Sikka; Yehudit Bergman; Jae Hyung Kim; Sungwoo Ryoo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-15       Impact factor: 8.311

Review 7.  Arginase in retinopathy.

Authors:  S Priya Narayanan; Modesto Rojas; Jutamas Suwanpradid; Haroldo A Toque; R William Caldwell; Ruth B Caldwell
Journal:  Prog Retin Eye Res       Date:  2013-07-03       Impact factor: 21.198

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.